Middle East And Africa Cough Syrup Market 2023-2030
Market Outlook
Triton Market Research’s report states that the cough syrup market in the Middle East and Africa is estimated to advance in value at a compound annual growth rate of 3.91% during the years 2023-2030. The UAE, Turkey, South Africa, Saudi Arabia, and Rest of Middle East & Africa are examined in the region.
The rapid urbanization and industrialization of major Turkish cities have resulted in increased air pollution. This rise in air pollutants can worsen respiratory conditions, causing persistent coughing, which prompts individuals to turn to cough syrups. In Turkey, there is a growing emphasis on health and wellness, leading people to take a more proactive approach to their well-being. This shift encourages individuals to seek healthcare products like cough syrups to address and prevent respiratory issues.
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the adult population of the UAE is a key factor influencing the demand for cough syrups in the country. COPD frequently leads to persistent and distressing coughing among affected individuals. Consequently, many COPD patients turn to over-the-counter cough syrups and related medications for relief from their cough symptoms. Given the significant COPD prevalence, the market for cough syrup is estimated to witness substantial growth.
Competitive Outlook
The notable companies in the cough syrup market are Cipla Limited, Kenvue Inc, AstraZeneca Plc, Acella Pharmaceuticals LLC, The Himalaya Wellness Company, Merck KGaA, Abbott Laboratories, and Glenmark Pharmaceuticals Limited.
1. Middle East And Africa Cough Syrup Market - Summary
2. Industry Outlook
2.1. Impact Analysis On The Cough Syrup Market
2.1.1. Covid-19 Impact
2.1.2. Ukraine-russia War Impact
2.2. Porter’s Five Forces Analysis
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Threat Of Competitive Rivalry
2.3. Industry Components
2.3.1. Raw Materials
2.3.2. Manufacturers
2.3.3. Distributors
2.3.4. Retailers
2.4. Regulatory Framework
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. High Incidence Of Respiratory Ailments
2.6.2. Vulnerability To Respiratory Diseases Among The Geriatric Population
2.6.3. Innovations In Cough Syrups
2.7. Market Challenges
2.7.1. Overdose Risks Associated With Cough Syrups
2.7.2. Strict Regulatory Requirements
2.7.3. Increasing Cough Syrup Deaths Due To Toxic Ingredients
2.8. Market Opportunities
2.8.1. Self-medication Trends Increase Demand For Otc Drugs
2.8.2. Herbal Cough Syrups Emerge As A Safer Alternative
2.8.3. Ease Of Purchase Offered By E-commerce Channels
2.8.4. Availability Of Sugar-free Cough Syrups
2.8.5. Growing Preference For Homeopathic Cough Syrups
2.9. Analyst Perspective
3. Middle East And Africa Cough Syrup Market – By Product Type
3.1. Cough Suppressants
3.2. Combination Medicines
3.3. Expectorants
4. Middle East And Africa Cough Syrup Market – By Age Group
4.1. Adults
4.2. Adolescents
4.3. Pediatric
5. Middle East And Africa Cough Syrup Market – By Distribution Channel
5.1. Retail Pharmacies
5.2. Hospital Pharmacies
5.3. E-pharmacies
6. Middle East And Africa Cough Syrup Market – By Country Outlook
6.1. United Arab Emirates
6.1.1. United Arab Emirates Cough Syrup Market Forecast & Prospects